908 Devices Inc.

NASDAQ:MASS

Medical - Devices

Healthcare
$9.52 +2.51%

+$0.22 today

Market cap
$395.86M
Beta
0.64
P/E (TTM)
-9.0
EPS (TTM)
-$0.97
52W Low $5.03High $9.34

Volume 0.25M

Average 0.27M

MASS Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

908 Devices Inc.NASDAQ: MASS

Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026

Depreciation & amortization declines year over year

Q1 FY2026 depreciation & amortization of $1.14M fell 11.8% year over year, behind the -7.0% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 2.0% from the prior quarter. Over 3 fiscal years it compounded at +40.4% a year.

Context

  • Depreciation & amortization amounted to 7.9% of revenue in FY2025, unchanged from a year earlier.
  • Depreciation & amortization increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -11.8% toward the trailing-twelve-month pace of -7.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.14M+2.0% QoQ
Last fiscal yearDec 2025
$4.47M-4.6% YoY
LTMMar 2026
$4.32M-7.0% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-11.8%——
1 year-4.6%——
3-year CAGR+40.4%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2025
4.47M USD
Year-over-year change
-4.6%
4-year CAGR
+48.2%

Depreciation & Amortization vs competitors

How MASS compares with its peers on the latest reported figures

  • MASS's LTM Mar 2026 depreciation & amortization of $4.32M is the lowest of the 3 companies compared; the peer median is $236.56M.
  • Its year-over-year change of -7.0% is the lowest of 3, against a peer median of +0.9%.
  • Depreciation & amortization amounts to 7.5% of revenue for MASS, versus a peer median of 6.6%.
MASS Competitors Peer median
Depreciation & Amortization for MASS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AAgilent Technologies, Inc.LTM Jul 2026$271M -5.2%-3.1%3.7%
QGENQiagen N.V.LTM Jun 2026$202.13M +7.0%-2.4%9.6%
MASS908 Devices Inc.LTM Mar 2026$4.32M -7.0%+40.4%7.5%
Peer median (excluding MASS) $236.56M+0.9%-2.8%6.6%

Competitors are the stored peer set for MASS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue42.21M46.85M50.23M59.63M56.2M
Cost of Revenue18.97M20.83M24.91M29.71M29.4M
Gross Profit23.23M26.02M25.32M29.93M26.8M
Gross Margin55.0%55.5%50.4%50.2%47.7%
Research & Development13.07M17.53M21.9M25.5M13.8M
Selling, General & Admin32.24M43.88M0037.18M
Operating Expenses45.3M61.41M68.08M106.64M50.98M
Depreciation & Amortization925K1.61M2.38M4.68M4.47M
EBITDA(20.76M)(31.82M)(40.27M)(43.88M)(28.88M)
EBITDA Margin-49.2%-67.9%-80.2%-73.6%-51.4%
Operating Income(22.07M)(35.38M)(42.76M)(76.72M)(24.18M)
Operating Margin-52.3%-75.5%-85.1%-128.7%-43.0%
Interest Income548K2.03M6.48M4.49M4.14M
Interest Expense486K129K201K00
Other Income / Expenses(100K)1.82M6.15M4.23M(9.16M)
Income Before Tax(22.17M)(33.56M)(36.61M)(72.49M)(33.34M)
Pre-Tax Margin-52.5%-71.6%-72.9%-121.6%-59.3%
Income Tax Expense00(211K)(282K)(66K)
Net Income(22.17M)(33.56M)(36.4M)(72.21M)(36.64M)
Net Margin-52.5%-71.6%-72.5%-121.1%-65.2%
EPS (Basic)(0.79)(1.07)(1.13)(2.12)0.54
EPS (Diluted)(0.79)(1.07)(1.13)(2.12)0.54
Weighted Avg Shares27.96M31.49M32.21M34.08M36.22M
Weighted Avg Shares (Diluted)27.96M31.49M32.24M34.08M38.92M

908 Devices Inc.

NASDAQ:MASS

Intrinsic Alpha fair value

Locked

Current Price

$9.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.